Aripiprazole/ sertraline combination: Clinical and cost-effectiveness in comparison with quetiapine for the treatment of bipolar depression. An open label randomised controlled trial. (ASCEnD)
Registered study from NIHR funded awards. Evidence status: source reported.
- Organisation
- Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
- Published
- 2022-09-01
- Source reference
- NIHR132773
- Jurisdiction
- United Kingdom (funder)
- Licence
- Open Government Licence v3.0. Contains public sector information from the NIHR Open Data portal; award holders' names not imported.
Contracted organisation: Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust · Programme: Health Technology Assessment · Award: £2,070,986 · 2022-09-01 to 2026-08-31 · Status: Active · Found via: a paper's funding metadata
Source: https://fundingawards.nihr.ac.uk/award/NIHR132773. Captured 2026-10-30.
Limitations: An NIHR funding award named, by its award number, in a held paper's funding metadata. The award funded research; it does not show which data the research used.